| Drotebanol Basic information |
Product Name: | Drotebanol | Synonyms: | Drotebanol;6b,14-Dihydroxy-3,4-dimethoxy-N-methylmorphinan;Dihydro-14-hydroxy-4-O-methyl-6b-thebainol;Dihydro-14-hydroxy-6b-thebainol 4-methyl ether;Metebanyl;Morphinan, 6b,14-dihydroxy-3,4-dimethoxy-N-methyl- (7CI);Morphinan-6,14-diol, 3,4-dimethoxy-17-methyl-, (6b)- (9CI);Morphinan-6b,14-diol, 3,4-dimethoxy-17-methyl- (8CI) | CAS: | 3176-03-2 | MF: | C19H27NO4 | MW: | 333.42 | EINECS: | | Product Categories: | Amines;Aromatics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals | Mol File: | 3176-03-2.mol | |
| Drotebanol Chemical Properties |
Melting point | 165.5-166.5° | Boiling point | 470.38°C (rough estimate) | density | 1.1618 (rough estimate) | refractive index | 1.5180 (estimate) | solubility | Chloroform (Slightly), Methanol (Slightly) | pka | 13.83±0.40(Predicted) | form | A solid |
Toxicity | LD50 in mice (mg/kg): 1300 orally, 1150 s.c., 91 i.v. (Kobayashi) | DEA Controlled Substances | CSCN: 9335 CSA SCH: Schedule I NARC: Yes |
| Drotebanol Usage And Synthesis |
Uses | An antitussive.
Controlled substance (opium derivative). | Definition | ChEBI: Oxymetebanol is an organic molecular entity. | Safety Profile | Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion. An antitussive agent. When heated to decomposition it emits toxic fumes of NOx. |
| Drotebanol Preparation Products And Raw materials |
|